Remove 2022 Remove Article Remove Packaging Remove Pharmaceutical Companies
article thumbnail

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward

ISPE

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. Wed, 11/02/2022 - 07:32. 2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. 2 November 2022. Trudy Patterson. iSpeak Blog. Susan Sandler. President, U.S. Business Unit and U.S. Country Head.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. 11 This requirement directly contradicts what is included in Article 63.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma within planetary boundaries

European Pharmaceutical Review

Seventy five percent of EU health systems’ emissions are released indirectly along the supply chain of pharmaceuticals, medical and other products. 2022; 6: 949-57. Hence, every country that looks at decarbonising its health sector – and all EU Member States must – will quickly look at the pharmaceutical industry.

article thumbnail

Potential and Challenges of the APAC Pharmaceutical Industry

Viseven

The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. In this article, we’ll focus on a pharmaceutical market in the APAC region, go through the differences between pharma in APAC and pharma in other parts of the world, and see the current state of the APAC pharma market.

article thumbnail

Why Are FDA Inspections So Ineffective and Disappointing?

The People's Pharmacy

In fiscal year 2019, the year before the COVID-19 pandemic limited travel and movement, the FDA inspected 37% of the nearly 2,500 overseas manufacturers; in 2022, the agency only inspected 6% of around 2,800.” Because of lax standards or outright fraud, the FDA has tried harder to visit drug companies in that country.

FDA 72
article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies. References.

article thumbnail

AI Retrofit: Tackling Challenges with Cutting-Edge Technologies

ISPE

Fri, 10/28/2022 - 10:39. November / December 2022. 1 November 2022. This artificial intelligence (AI) retrofit project was a unique approach to implementing AI technology in a pharmaceutical environment within three months. AI Retrofit: Tackling Challenges with Cutting-Edge Technologies. Trudy Patterson. Julien Janda.